news

 

Startup and entrepreneurship-focused firm Burgeon Law has significantly bolstered its Delhi capabilities with the addition of a team of two partners and five fee-earners from Dentons Link Legal.

Ketan Mukhija (L) joins as senior partner and Abhinav Agnihotri as partner, bringing the 2015-founded firm’s total partner strength to six.

Mukhija has more than sixteen years’ experience in the M&A sector, and also has four years of in-house experience as a senior vice president at Indian conglomerate Srei.

Agnihotri is a disputes lawyer with a particular focus on the construction, infrastructure, public law and white-collar crime sectors. He will build Burgeon’s dispute resolution practice.

“While we’ve successfully evolved from a PE-VC focused firm to a multi-service firm in recent years, their arrival brings a wealth of experience in corporate-commercial transactions, advisory and disputes, thus truly making us full-service in most respects. This expansion has diversified the firm’s practice into areas such as projects and dispute resolution, along with a more robust corporate practice spanning almost all industry sectors,” Burgeon’s founding partner Roma Priya said in a statement.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

CAM, WFW act on $185 mln Adani Ports acquisition

by Nimitt Dixit |

Cyril Amarchand Mangaldas advised its longstanding client Adani on Adani Ports and Special Economic Zone’s acquisition of 80 percent stake in Astro Offshore, an offshore support vessel operator. Watson Farley & Williams advised the selling shareholders of Astro Offshore.

Anagram adds M&A and PE partner from IndusLaw

by Nimitt Dixit |

M&A-focused Anagram Partners has become the latest to turn to IndusLaw to expand its offerings with the addition of M&A and private equity-focused partner Faraz Khan in Mumbai.

Trilegal, Latham, Quillon act on Platinum Equity’s India PE debut

by Nimitt Dixit |

Trilegal and Latham & Watkins have advised U.S.-based buyout fund Platinum Equity on its debut private equity deal in India, in the form of the acquisition of a majority stake in Inventia Healthcare, a Mumbai-based pharmaceutical company, at a valuation of $300 million.